TAT 2019: Programme

The 17th edition of the International Congress on Targeted Anticancer Therapies (TAT) will take place in Paris, 25-27 February 2019.

In the TAT 2019 programme, major updates and innovation in the field of cancer treatment using exciting novel targeted agents and immunotherapy will be presented along with new points to consider including the role of microbiome in drug development. The issue of combination in the use of immuno-oncology agents will be largely discussed as well as new immunotherapy approaches and methodological issues. In addition to the usual congress sessions, Workshops at lunch time and “Meet the expert” sessions are planned to allow interactivity among the participants

View the online programme

Accreditation

ESMO-MORA: The TAT 2019 programme will be submitted for ESMO-MORA category 1 points accreditation. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.